Skip to main content
 

Our Elmiron News

Below are some of our news stories explaining the potential dangers of Elmiron, and especially the connection to Pigmentary Maculopathy. To learn more about the types of injuries that have been linked to this medication, and the legal claims that have been filed, click Elmiron.

 
Wednesday, August 24, 2022

Many of the four-to-twelve million people who suffer from interstitial cystitis (IC) (a painful, chronic bladder condition) have sought relief from their symptoms by taking the prescription…

Sunday, December 6, 2020

A federal judge has blocked the class action lawsuit proposed in Almond v. Janssen Pharmaceuticals,…

Wednesday, October 28, 2020

An explosion of recent studies from multiple university medical centers recently exposed that the use of the prescription drug Elmiron® can result in patients’ vision failure, up to and including…

Tuesday, October 20, 2020

With 80 product liability lawsuits already filed and hundreds more likely to follow, lawyers are discussing the coordination of multi-district litigation (MDL). To date, legal action has been…

Wednesday, May 18, 2022

The Elmiron lawsuits claim that long-term exposure to Elmiron causes maculopathy, an eye disorder affecting the macula (central part of the retina) and a major cause of blindness.

Our law…

Subscribe to Elmiron News